-
公开(公告)号:US10807931B2
公开(公告)日:2020-10-20
申请号:US16639202
申请日:2018-08-16
发明人: Tristan Reekie , Michael Scott , Michael Kassiou
IPC分类号: C07C37/50 , C07C39/15 , C07D311/58 , C07D311/80 , C07D311/94
摘要: Method for decarboxylating a carboxylated phytocannabinoid compound of Formula I to form a phytocannabinoid compound of Formula II: Formula I Formula II wherein: R1 is selected from the group consisting of: substituted or unsubstituted C1-C5 alkyl; R2 is selected from the group consisting of: OH or O, and R3 is selected from the group consisting of: a substituted or unsubstituted cyclohexene, a substituted or unsubstituted C2-C8 alkene, or a substituted or unsubstituted C2-C8 dialkene; or R2 is O, and R2 and R3 together form a ring structure in which R2 is an internal ring atom; wherein the method includes heating a reaction mixture comprising the carboxylated phytocannabinoid compound and a polar aprotic solvent in the presence of a LiCl for a time sufficient to decarboxylate at least a portion of the carboxylated phytocannabinoid compounds and form the phytocannabinoid compound.
-
公开(公告)号:US11472774B2
公开(公告)日:2022-10-18
申请号:US16965398
申请日:2019-02-01
发明人: Michael Kassiou , William Jorgensen , Lenka Munoz
IPC分类号: C07D213/75 , C07D213/82 , C07D241/24 , C07D307/66 , C07D317/66
摘要: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer). In some embodiments, the present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or prodrugs thereof.
-
公开(公告)号:US20210323910A1
公开(公告)日:2021-10-21
申请号:US17269244
申请日:2018-08-24
IPC分类号: C07C235/60 , A61P25/28
摘要: The present invention relates to adamantanyl-substituted benzamide compounds and their use as antagonists of the P2X7 purinoreceptor. The invention further relates to methods for the treatment of disease and conditions associated with the P2X7 purinoreceptor.
-
公开(公告)号:US20210163438A1
公开(公告)日:2021-06-03
申请号:US16639194
申请日:2018-08-16
发明人: Tristan Reekie , Michael Scott , Michael Kassiou
IPC分类号: C07D311/80 , C07D311/04 , C07C51/09 , C07C65/19
摘要: A method for demethylating a methylated phytocannabinoid compound of Formula I to form a phytocannabinoid compound of Formula II: Formula I Formula II wherein: R1 is selected from the group consisting of: substituted or unsubstituted C1-C5 alkyl; R2 is selected from the group consisting of: OH or O, and R3 is selected from the group consisting of: a substituted or unsubstituted cyclohexene, a substituted or unsubstituted C2-C8 alkene, or a substituted or unsubstituted C2-C8 dialkene; or R2 is O, and R2 and R3 together form a ring structure in which R2 is an internal ring atom; wherein the method includes: heating a reaction mixture comprising the methylated phytocannabinoid compounds and a polar aprotic solvent in the presence of a dissolved inorganic alkaline salt for a time sufficient to demethylate at least a portion of the methylated phytocannabinoid compounds and form the phytocannabinoid compound.
-
公开(公告)号:US20200172459A1
公开(公告)日:2020-06-04
申请号:US16639202
申请日:2018-08-16
发明人: Tristan Reekie , Michael Scott , Michael Kassiou
IPC分类号: C07C37/50 , C07C39/15 , C07D311/94 , C07D311/80 , C07D311/58
摘要: method for decarboxylating a carboxylated phytocannabinoid compound of Formula I to form a phytocannabinoid compound of Formula II: Formula I Formula II wherein: R1 is selected from the group consisting of: substituted or unsubstituted C1-C5 alkyl; R2 is selected from the group consisting of: OH or O, and R3 is selected from the group consisting of: a substituted or unsubstituted cyclohexene, a substituted or unsubstituted C2-C8 alkene, or a substituted or unsubstituted C2-C8 dialkene; or R2 is O, and R2 and R3 together form a ring structure in which R2 is an internal ring atom; wherein the method includes heating a reaction mixture comprising the carboxylated phytocannabinoid compound and a polar aprotic solvent in the presence of a LiCl for a time sufficient to decarboxylate at least a portion of the carboxylated phytocannabinoid compounds and form the phytocannabinoid compound.
-
公开(公告)号:US20180273478A1
公开(公告)日:2018-09-27
申请号:US15547227
申请日:2016-01-29
IPC分类号: C07D213/61 , C07D213/56 , C07D239/34 , C07C233/11 , C07D239/26 , C07C233/29 , C07D215/14 , A61P35/00
CPC分类号: C07D213/61 , A61P35/00 , C07C233/11 , C07C233/29 , C07C237/20 , C07D213/56 , C07D215/14 , C07D239/26 , C07D239/34
摘要: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
-
公开(公告)号:US20240182419A1
公开(公告)日:2024-06-06
申请号:US18441515
申请日:2024-02-14
发明人: Michael Kassiou , William Jorgensen , Lenka Munoz
IPC分类号: C07D213/75 , A61K31/4406 , A61K31/4409 , A61K31/4965 , C07D213/82 , C07D241/24 , C07D307/66 , C07D317/66
CPC分类号: C07D213/75 , A61K31/4406 , A61K31/4409 , A61K31/4965 , C07D213/82 , C07D241/24 , C07D307/66 , C07D317/66
摘要: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
-
公开(公告)号:US11939296B2
公开(公告)日:2024-03-26
申请号:US17899297
申请日:2022-08-30
发明人: Michael Kassiou , William Jorgensen , Lenka Munoz
IPC分类号: A61K31/4409 , A61K31/4406 , A61K31/4965 , C07D213/75 , C07D213/82 , C07D241/24 , C07D307/66 , C07D317/66
CPC分类号: C07D213/75 , A61K31/4406 , A61K31/4409 , A61K31/4965 , C07D213/82 , C07D241/24 , C07D307/66 , C07D317/66
摘要: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
-
公开(公告)号:US10745355B2
公开(公告)日:2020-08-18
申请号:US15547227
申请日:2016-01-29
IPC分类号: A61K31/505 , A61K31/47 , A61K31/44 , A61K31/195 , A61K31/192 , C07D213/61 , C07D215/14 , C07D239/26 , C07D239/34 , C07C233/11 , C07C233/29 , C07D213/56 , C07C237/20 , A61P35/00
摘要: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
-
-
-
-
-
-
-
-